Narrow search
Showing 1 - 3 of 3
Cover Image
Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland
Lebioda, Andrea; Gasche, David; Dippel, Franz-Werner; … - In: Health Economics Review 4 (2014) 31, pp. 1-14
Early benefit assessment in Germany under the legislative framework of AMNOG (Arzneimittelmarktneuordnungsgesetz) requires direct comparisons of the new drug with appropriate comparators determined by the Federal Joint Committee (G-BA). In case no head-to-head studies are available for direct...
Persistent link: https://www.econbiz.de/10011599783
Cover Image
Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland
Lebioda, Andrea; Gasche, David; Dippel, Franz-Werner; … - In: Health economics review 4 (2014) 31, pp. 1-14
Early benefit assessment in Germany under the legislative framework of AMNOG (Arzneimittelmarktneuordnungsgesetz) requires direct comparisons of the new drug with appropriate comparators determined by the Federal Joint Committee (G-BA). In case no head-to-head studies are available for direct...
Persistent link: https://www.econbiz.de/10010526947
Cover Image
Pharmamarkt Deutschland
Borchert, Katja; Harms, Fred; Plantör, Stefan; Ahlert, … - In: Pharmamarketing : gesundheitsökonomische Aspekte einer …, (pp. 7-59). 2008
Persistent link: https://www.econbiz.de/10003743686